2,3-bis(4-hydroxyphenyl)-propionitrile and Colonic Neoplasms

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Colonic Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Mełeń-Mucha, G; Motylewska, E; Stasikowska, O	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Colonic Neoplasms

Article	Year
The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer letters, 2009, Apr-08, Volume: 276, Issue:1 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Estrogen Receptor beta; Humans; Immunohistochemistry; Mice; Nitriles; Propionates; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators	2009

Article

Year

The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line.

Cancer letters, 2009, Apr-08, Volume: 276, Issue:1

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Estrogen Receptor beta; Humans; Immunohistochemistry; Mice; Nitriles; Propionates; Receptors, Estrogen; Receptors, Progesterone; Selective Estrogen Receptor Modulators

2009